SYNTA PHARMACEUTICALS CORP
SYNTA PHARMACEUTICALS CORP (SNTA) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 347 transactions totaling $99.3M, demonstrating a bullish sentiment with $81.8M in net insider flow. The most recent transaction on Jan 1, 2016 involved a transaction of 17,857 shares valued at $0.
SNTA Insider Activity Summary
Who Is Buying SNTA Stock?
No significant insider buying has been recorded for SNTA in the recent period.
Who Is Selling SNTA Stock?
No significant insider selling has been recorded for SNTA in the recent period.
Is SYNTA PHARMACEUTICALS CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SNTA is bullish with an Insider Alignment Score of 91/100 and a net flow of $81.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SNTA Frequently Asked Questions
Understanding SNTA Insider Activity
Insider trading at SYNTA PHARMACEUTICALS CORP (SNTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading SNTA stock, having executed 347 transactions in the past 90 days. The most active insider is Bruce Kovner (Executive), who has made 133 transactions totaling $134.1M.
Related Tools
Track SYNTA PHARMACEUTICALS CORP Insider Activity
Get notified when executives and directors at SNTA file new Form 4 transactions